夏枯草口服液在甲状腺功能亢进症患者中的应用

目的：观察夏枯草口服液在甲状腺功能亢进症时对甲状腺大小的影响。方法：56例甲状腺功能亢进(简称甲亢组)患者随机分为经典治疗组(A₁组)和联用夏枯草口服液治疗组(B₁组),治疗前后行甲状腺彩超检查甲状腺大小、实质内的彩色血流清况,同时测量20例正常人作为对照组。结果：治疗前甲状腺大小、甲状腺上动脉管径、血流速度及血流量均明显大于正常组(P<0.001),治疗后,经典治疗组和联用夏枯草口服液治疗组甲状腺均有不同程度缩小,甲状腺上动脉管径变小、血流速度及血流量逐渐下降,但甲状腺大小以联用夏枯草口服液治疗组为明显,此组与正常对照组相比已无明显差异,甲状腺甲状腺上动脉、血流速度及血流量两组之间比较无明显差异。结论：甲状腺功能亢进症时,在经典治疗基础上联用夏枯草口服液治疗甲状腺肿大,疗效肯定,中西医结合治疗优于单纯用西药治疗,值得临床推广应用。

Clinical effect of prunrllae oral solution in treating hyperthyrea

Objective: To observe the clinical effects of prunrllae oral solution in treating hyperthyrea. Method: 56 cases with hyperthyrea were randomized into two groups; group A₁ was treated by classic method, B₁ was treated by classic method combined with prunrllae oral solution. The size, vessel caliber of thyroidea, volume of blood flow and blood flow rate pre-and post-treatment were measured by color supersonic, meanwhile, 20 normal thyroidea were measured as control group. Result: The size and vessel caliber of thyroidea of the two groups pre-treatment were obviously bigger than those of the control group, the volume of blood flow and blood flow rate were obviously slower than those of the control group (P<0.001), the sizes of thyroidea of the two groups became smaller, especially the group B1 was more obvious, and there was no significant difference in the size of thyroidea between group B1and control group. Conclusion: It is indicated that combined treatment of traditional Chinese medicine (prunrllae oral solution) and western medicine is superior to western medicine in treating hyperthyrea.